ENTITY
111 Inc

111 Inc (YI US)

124
Analysis
Information Technology • China
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
more
bullish•NIO
•15 Sep 2018 10:36

ECM Weekly (15 September 2018) - Fast & Furious - NIO, Qutoutiao, Haidilao, Viomi, X Financial

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
bearish•Meituan
•10 Sep 2018 05:50

Last Week in GER Research: Meituan, China Tower, Haidilao, Qutoutiao, Hua Med., Chunlai, and Cootek

Below is a recap of the key IPO research produced by the Global Equity Research team. This week we assess Meituan's latest results ahead of its...

Logo
464 Views
Share
bullish•Meituan
•08 Sep 2018 13:18

ECM Weekly (8 September 2018) - Qutoutiao, Viomi, 111 Inc., Meituan, Haidilao

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
bearish•111 Inc
•04 Sep 2018 11:01

111 Inc. (1药网) IPO Review - Key Operating Metrics of B2C Segment Has Been Declining

111 Inc (YI US) is looking to raise up to about US$150m in its upcoming IPO. Proceeds from IPO will be mainly used for research and development and...

Share
bearish•Meituan
•03 Sep 2018 06:48

Last Week in GER Research: Meituan-Dianping, Nio, Gangfeng Lithium, Pinduoduo and 111 Inc

Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we highlight a more palatable...

Logo
492 Views
Share
x